查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1726267

全球停经后骨质疏鬆症治疗市场：市场规模、份额和趋势分析（按药物类别、类型、分销管道和地区），按细分市场预测（2025-2030 年）

Postmenopausal Osteoporosis Treatment Market Size, Share & Trends Analysis Report By Drug Class (Branded, Generics), By Type (Bisphosphates, Parathyroid Hormone Therapy), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

停经后骨质疏鬆症治疗市场的成长与趋势：

根据 Grand View Research, Inc. 的新报告，全球停经后骨质疏鬆症治疗市场预计到 2030 年将达到 137 亿美元，2025 年至 2030 年的复合年增长率为 4.6%。

由于老年人口的增加和生活方式的改变，市场正在经历显着增长。由于老年人口极易受到影响，预计将成为市场扩张的主要驱动力。例如，根据世界卫生组织 (WHO) 2021 年 10 月的报告，预计 60 岁及以上人口数量将从 2020 年的 10 亿增加到 2030 年的 14 亿，到 2050 年将达到 21 亿。因此，由于老年人对停经后骨质疏鬆症治疗的需求不断增加，预计市场在预测期内将会扩大。

此外，缺乏运动、过度饮酒、吸烟、长时间工作和不健康的饮食习惯等不良的生活习惯会影响更年期，并增加全球许多女性患骨质疏鬆症的风险。此外，年龄、吸烟、饮酒、过量使用促性腺激素分泌和甲状腺激素以及使用细胞毒性药物等抗病药物都是导致停经后妇女骨骼密度下降和症状的一些风险因素。这将成为市场成长的驱动力。根据国际更年期协会（IMS）的统计，预计2021年将有超过2亿女性罹患骨质疏鬆症，50岁以上女性中每3人中就有1人会遭遇骨质疏鬆性骨折。由于上述因素，预计市场在预测期内将会扩大。

然而，预测期内人们预计对该疾病的认识不足将阻碍该行业的发展。在预测期内，由于产业参与者和研究机构的投资，研发力道可能会大幅增加。例如，根据 clinicaltrial.gov 上发布的信息，截至 2021 年 6 月，美国正在进行大约 25 项骨质疏鬆症药物的 III 期和 IV 期临床试验。例如，礼来公司发展出人源化 IgG4 单株抗体 brosozumab，用于治疗停经后骨质疏鬆症。它是SOST蛋白的抑制剂，目前正处于II期临床试验阶段。

停经后骨质疏鬆症治疗市场报告重点

  • 品牌骨质疏鬆症药物将占据市场主导地位，到 2024 年将占 54.0% 的份额。这些药物因其经过验证的疗效、监管部门的核准和强大的市场占有率而被广泛使用。
  • 2024年，零售药局将占据市场主导地位。老年人口的成长和骨质疏鬆症盛行率的上升是推动透过此通路销售药品需求的主要因素。
  • 由于主要市场参与企业的强大影响力、研发支出的增加以及联邦政府的支持，北美在 2024 年占据了最大的份额。
  • 由于目标疾病盛行率上升、人口老化加剧以及停经后骨质疏鬆症药物的采用率增加，预计亚太地区在预测期内的复合年增长率最高。

目录

第一章 分析方法与范围

第二章执行摘要

第三章停经后骨质疏鬆症治疗市场：驱动因素、趋势与范围

  • 市场联动展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制分析
  • 商业环境分析
    • 产业分析：波特五力分析
    • PESTEL分析

第四章停经后骨质疏鬆症治疗市场：依药物类别分類的业务分析

  • 各药品类别的市场占有率（2024 年及 2030 年）
  • 药物类别仪表板
  • 依药品类别分類的市场规模预测及趋势分析（2018-2030年）
  • 品牌
  • 学名药

第五章停经后骨质疏鬆症治疗市场：按类型分類的业务分析

  • 按类型分類的市场占有率（2024 年和 2030 年）
  • 按类型分類的仪表板
  • 按类型分類的市场规模预测和趋势分析（2018-2030）
  • 双磷酸盐
  • 副甲状腺素治疗
  • 抑钙素
  • 选择性雌激素抑制剂调变器（SERM）
  • 活化因数配体抑制剂
  • 其他产品

第六章停经后骨质疏鬆症治疗市场：通路业务分析

  • 按分销管道分類的市场占有率（2024 年和 2030 年）
  • 分销通路仪表板
  • 按分销管道分類的市场规模预测和趋势分析（2018-2030 年）
  • 医院药房
  • 零售药局
  • 网路药局

第七章停经后骨质疏鬆症治疗市场：按地区估计和趋势分析

  • 各地区市场占有率分析（2024 年及 2030 年）
  • 市场仪表板：按地区
  • 市场规模预测及趋势分析（2018-2030年）
  • 北美洲
    • 按国家/地区（2018-2030 年）
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 按国家/地区（2018-2030 年）
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 丹麦
    • 瑞典
  • 亚太地区
    • 按国家/地区（2018-2030 年）
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 按国家/地区（2018-2030 年）
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 按国家/地区（2018-2030 年）
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争态势

  • 参与者概览
  • 公司市场地位分析
  • 公司分类
  • 战略地图
  • 公司简介/上市公司
    • Amgen Inc.
    • Eli Lilly and Company
    • Merck &Co., Inc.
    • Novartis AG
    • Pfizer Inc.
    • AbbVie Inc.
    • Cipla
    • Teva Pharmaceutical Industries Ltd.
    • F. Hoffmann-La Roche Ltd
Product Code: GVR-4-68040-065-0

Postmenopausal Osteoporosis Treatment Market Growth & Trends:

The global postmenopausal osteoporosis treatment market size is expected to reach USD 13.7 billion by 2030 and is expected to expand at a CAGR of 4.6% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market has grown significantly as a result of the growing geriatric population and lifestyle changes. As the older population is more susceptible, their population growth is anticipated to be a major driving force behind the market expansion. For instance, the number of people aged 60 years and above is predicted to rise from 1 billion in 2020 to 1.4 billion by 2030 and 2.1 billion by 2050, according to the World Health Organization's October 2021 report. As a result, the market is anticipated to expand during the forecast period due to a rise in demand for postmenopausal osteoporosis treatment among older people.

In addition, lifestyle modifications like inactivity, excessive alcohol consumption, smoking, long work hours, and unhealthy eating patterns have an impact on menopause and increase the risk of osteoporosis in many women around the globe. Furthermore, age, smoking, alcohol consumption, and the use of drugs to address illnesses like gonadotropins, excessive thyroid hormone use, & cytotoxic agents are a few of the risk factors that can lead to low bone density and the development of the condition in women after menopause. Thus, it will drive the market growth. In 2021, more than 200 million women were affected with osteoporosis, and 1 in 3 women over 50 years of age are predicted to sustain an osteoporosis fracture, according to statistics from the International Menopause Society (IMS). As a result of the aforementioned factors, it is anticipated that the studied market will expand over the projected period.

However, it is anticipated that during the projection era, low awareness about the disease will impede industry growth. In the forecast period, there will likely be a significant increase in research and development efforts as a result of investments made by industry participants and research institutions. For instance, according to the information posted on clinicaltrial.gov, as of June 2021, there were approximately 25 ongoing phase III as well as phase IV clinical trials for osteoporosis medications in the U.S. Consequently, as a result of the aforementioned factors, the market is expected to grow over the forecast period. For instance, Eli Lilly and Company is creating blosozumab, a humanized IgG4 monoclonal antibody, to treat postmenopausal osteoporosis. It is an inhibitor of the SOST protein and is presently undergoing phase II clinical studies.

Postmenopausal Osteoporosis Treatment Market Report Highlights:

  • Branded osteoporosis drugs dominated the market, accounting for a share of 54.0% in 2024. These medications are widely used due to their proven effectiveness, regulatory approvals, and strong market presence.
  • Retail pharmacies dominated the market in 2024. The growing geriatric population and the increasing prevalence of osteoporosis have been key factors driving the demand for medications through this distribution channel.
  • North America held the largest share in 2024 due to the strong presence of key market participants, as well as rising R&D spending and federal assistance, in the region
  • Asia Pacific is expected to grow at the highest CAGR over the projected period due to the rising prevalence of target disease, the growing aging population, and the increasing adoption of postmenopausal osteoporosis treatments

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Drug Class
    • 1.2.2. Type
    • 1.2.3. Distribution Channel
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Postmenopausal Osteoporosis Treatment Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Postmenopausal Osteoporosis Treatment Market: Drug Class Business Analysis

  • 4.1. Drug Class Market Share, 2024 & 2030
  • 4.2. Drug Class Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Drug Class, 2018 to 2030 (USD Million)
  • 4.4. Branded
    • 4.4.1. Branded Market, 2018 - 2030 (USD Million)
  • 4.5. Generics
    • 4.5.1. Generics Market, 2018 - 2030 (USD Million)

Chapter 5. Postmenopausal Osteoporosis Treatment Market: Type Business Analysis

  • 5.1. Type Market Share, 2024 & 2030
  • 5.2. Type Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 5.4. Bisphosphonates
    • 5.4.1. Bisphosphonates Market, 2018 - 2030 (USD Million)
  • 5.5. Parathyroid Hormone Therapy
    • 5.5.1. Parathyroid Hormone Therapy Market, 2018 - 2030 (USD Million)
  • 5.6. Calcitonin
    • 5.6.1. Calcitonin Market, 2018 - 2030 (USD Million)
  • 5.7. Selective Estrogen Inhibitors Modulator (SERM)
    • 5.7.1. Selective Estrogen Inhibitors Modulator (SERM) Market, 2018 - 2030 (USD Million)
  • 5.8. Rank Ligand Inhibitors
    • 5.8.1. Rank Ligand Inhibitors Market, 2018 - 2030 (USD Million)
  • 5.9. Other Products
    • 5.9.1. Other Products Market, 2018 - 2030 (USD Million)

Chapter 6. Postmenopausal Osteoporosis Treatment Market: Distribution Channel Business Analysis

  • 6.1. Distribution Channel Market Share, 2024 & 2030
  • 6.2. Distribution Channel Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
  • 6.4. Hospital Pharmacies
    • 6.4.1. Hospital Pharmacies Market, 2018 - 2030 (USD Million)
  • 6.5. Retail Pharmacies
    • 6.5.1. Retail Pharmacies Market, 2018 - 2030 (USD Million)
  • 6.6. Online Pharmacies
    • 6.6.1. Online Pharmacies Market, 2018 - 2030 (USD Million)

Chapter 7. Postmenopausal Osteoporosis Treatment Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. North America Postmenopausal Osteoporosis Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory Framework
      • 7.4.2.3. Competitive Insights
      • 7.4.2.4. U.S. Postmenopausal Osteoporosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory Framework
      • 7.4.3.3. Competitive Insights
      • 7.4.3.4. Canada Postmenopausal Osteoporosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Regulatory Framework
      • 7.4.4.3. Competitive Insights
      • 7.4.4.4. Mexico Postmenopausal Osteoporosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Postmenopausal Osteoporosis Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Framework
      • 7.5.2.3. Competitive Insights
      • 7.5.2.4. UK Postmenopausal Osteoporosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Framework
      • 7.5.3.3. Competitive Insights
      • 7.5.3.4. Germany Postmenopausal Osteoporosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Framework
      • 7.5.4.3. Competitive Insights
      • 7.5.4.4. France Postmenopausal Osteoporosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Regulatory Framework
      • 7.5.5.3. Competitive Insights
      • 7.5.5.4. Italy Postmenopausal Osteoporosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Regulatory Framework
      • 7.5.6.3. Competitive Insights
      • 7.5.6.4. Spain Postmenopausal Osteoporosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Norway
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Regulatory Framework
      • 7.5.7.3. Competitive Insights
      • 7.5.7.4. Norway Postmenopausal Osteoporosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Denmark
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Regulatory Framework
      • 7.5.8.3. Competitive Insights
      • 7.5.8.4. Denmark Postmenopausal Osteoporosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Sweden
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Regulatory Framework
      • 7.5.9.3. Competitive Insights
      • 7.5.9.4. Sweden Postmenopausal Osteoporosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Postmenopausal Osteoporosis Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Framework
      • 7.6.2.3. Competitive Insights
      • 7.6.2.4. Japan Postmenopausal Osteoporosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Framework
      • 7.6.3.3. Competitive Insights
      • 7.6.3.4. China Postmenopausal Osteoporosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Framework
      • 7.6.4.3. Competitive Insights
      • 7.6.4.4. India Postmenopausal Osteoporosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Framework
      • 7.6.5.3. Competitive Insights
      • 7.6.5.4. South Korea Postmenopausal Osteoporosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Framework
      • 7.6.6.3. Competitive Insights
      • 7.6.6.4. Australia Postmenopausal Osteoporosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Regulatory Framework
      • 7.6.7.3. Competitive Insights
      • 7.6.7.4. Thailand Postmenopausal Osteoporosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Postmenopausal Osteoporosis Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Framework
      • 7.7.2.3. Competitive Insights
      • 7.7.2.4. Brazil Postmenopausal Osteoporosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Framework
      • 7.7.3.3. Competitive Insights
      • 7.7.3.4. Argentina Postmenopausal Osteoporosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA Postmenopausal Osteoporosis Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Framework
      • 7.8.2.3. Competitive Insights
      • 7.8.2.4. South Africa Postmenopausal Osteoporosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Framework
      • 7.8.3.3. Competitive Insights
      • 7.8.3.4. Saudi Arabia Postmenopausal Osteoporosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Framework
      • 7.8.4.3. Competitive Insights
      • 7.8.4.4. UAE Postmenopausal Osteoporosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Regulatory Framework
      • 7.8.5.3. Competitive Insights
      • 7.8.5.4. Kuwait Postmenopausal Osteoporosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Amgen Inc.
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. Eli Lilly and Company
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Merck & Co., Inc.
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Novartis AG
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Pfizer Inc.
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. AbbVie Inc.
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. Cipla
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. Teva Pharmaceutical Industries Ltd.
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. F. Hoffmann-La Roche Ltd
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global Postmenopausal Osteoporosis Treatment Market, by region, 2018 - 2030 (USD Million)
  • Table 4 Global Postmenopausal Osteoporosis Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 5 Global Postmenopausal Osteoporosis Treatment Market, by Type, 2018 - 2030 (USD Million)
  • Table 6 Global Postmenopausal Osteoporosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 7 North America Postmenopausal Osteoporosis Treatment Market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America Postmenopausal Osteoporosis Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 9 North America Postmenopausal Osteoporosis Treatment Market, by Type, 2018 - 2030 (USD Million)
  • Table 10 North America Postmenopausal Osteoporosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 11 U.S. Postmenopausal Osteoporosis Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 12 U.S. Postmenopausal Osteoporosis Treatment Market, by Type, 2018 - 2030 (USD Million)
  • Table 13 U.S. Postmenopausal Osteoporosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 14 Canada Postmenopausal Osteoporosis Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 15 Canada Postmenopausal Osteoporosis Treatment Market, by Type, 2018 - 2030 (USD Million)
  • Table 16 Canada Postmenopausal Osteoporosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 17 Mexico Postmenopausal Osteoporosis Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 18 Mexico Postmenopausal Osteoporosis Treatment Market, by Type, 2018 - 2030 (USD Million)
  • Table 19 Mexico Postmenopausal Osteoporosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 20 Europe Postmenopausal Osteoporosis Treatment Market, by country, 2018 - 2030 (USD Million)
  • Table 21 Europe Postmenopausal Osteoporosis Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 22 Europe Postmenopausal Osteoporosis Treatment Market, by Type, 2018 - 2030 (USD Million)
  • Table 23 Europe Postmenopausal Osteoporosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 24 UK Postmenopausal Osteoporosis Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 25 UK Postmenopausal Osteoporosis Treatment Market, by Type, 2018 - 2030 (USD Million)
  • Table 26 UK Postmenopausal Osteoporosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 27 Germany Postmenopausal Osteoporosis Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 28 Germany Postmenopausal Osteoporosis Treatment Market, by Type, 2018 - 2030 (USD Million)
  • Table 29 Germany Postmenopausal Osteoporosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 30 France Postmenopausal Osteoporosis Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 31 France Postmenopausal Osteoporosis Treatment Market, by Type, 2018 - 2030 (USD Million)
  • Table 32 France Postmenopausal Osteoporosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 33 Italy Postmenopausal Osteoporosis Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 34 Italy Postmenopausal Osteoporosis Treatment Market, by Type, 2018 - 2030 (USD Million)
  • Table 35 Italy Postmenopausal Osteoporosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 36 Spain Postmenopausal Osteoporosis Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 37 Spain Postmenopausal Osteoporosis Treatment Market, by Type, 2018 - 2030 (USD Million)
  • Table 38 Spain Postmenopausal Osteoporosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 39 Norway Postmenopausal Osteoporosis Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 40 Norway Postmenopausal Osteoporosis Treatment Market, by Type, 2018 - 2030 (USD Million)
  • Table 41 Norway Postmenopausal Osteoporosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 42 Denmark Postmenopausal Osteoporosis Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 43 Denmark Postmenopausal Osteoporosis Treatment Market, by Type, 2018 - 2030 (USD Million)
  • Table 44 Denmark Postmenopausal Osteoporosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 45 Sweden Postmenopausal Osteoporosis Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 46 Sweden Postmenopausal Osteoporosis Treatment Market, by Type, 2018 - 2030 (USD Million)
  • Table 47 Sweden Postmenopausal Osteoporosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Postmenopausal Osteoporosis Treatment Market, by country, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Postmenopausal Osteoporosis Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Postmenopausal Osteoporosis Treatment Market, by Type, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific Postmenopausal Osteoporosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 52 Japan Postmenopausal Osteoporosis Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 53 Japan Postmenopausal Osteoporosis Treatment Market, by Type, 2018 - 2030 (USD Million)
  • Table 54 Japan Postmenopausal Osteoporosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 55 China Postmenopausal Osteoporosis Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 56 China Postmenopausal Osteoporosis Treatment Market, by Type, 2018 - 2030 (USD Million)
  • Table 57 China Postmenopausal Osteoporosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 58 India Postmenopausal Osteoporosis Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 59 India Postmenopausal Osteoporosis Treatment Market, by Type, 2018 - 2030 (USD Million)
  • Table 60 India Postmenopausal Osteoporosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 61 Australia Postmenopausal Osteoporosis Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 62 Australia Postmenopausal Osteoporosis Treatment Market, by Type, 2018 - 2030 (USD Million)
  • Table 63 Australia Postmenopausal Osteoporosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 64 South Korea Postmenopausal Osteoporosis Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 65 South Korea Postmenopausal Osteoporosis Treatment Market, by Type, 2018 - 2030 (USD Million)
  • Table 66 South Korea Postmenopausal Osteoporosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 67 Thailand Postmenopausal Osteoporosis Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 68 Thailand Postmenopausal Osteoporosis Treatment Market, by Type, 2018 - 2030 (USD Million)
  • Table 69 Thailand Postmenopausal Osteoporosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 70 Latin America Postmenopausal Osteoporosis Treatment Market, by country, 2018 - 2030 (USD Million)
  • Table 71 Latin America Postmenopausal Osteoporosis Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 72 Latin America Postmenopausal Osteoporosis Treatment Market, by Type, 2018 - 2030 (USD Million)
  • Table 73 Latin America Postmenopausal Osteoporosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 74 Brazil Postmenopausal Osteoporosis Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 75 Brazil Postmenopausal Osteoporosis Treatment Market, by Type, 2018 - 2030 (USD Million)
  • Table 76 Brazil Postmenopausal Osteoporosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 77 Argentina Postmenopausal Osteoporosis Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 78 Argentina Postmenopausal Osteoporosis Treatment Market, by Type, 2018 - 2030 (USD Million)
  • Table 79 Argentina Postmenopausal Osteoporosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa Postmenopausal Osteoporosis Treatment Market, by country, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa Postmenopausal Osteoporosis Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa Postmenopausal Osteoporosis Treatment Market, by Type, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa Postmenopausal Osteoporosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 84 South Africa Postmenopausal Osteoporosis Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 85 South Africa Postmenopausal Osteoporosis Treatment Market, by Type, 2018 - 2030 (USD Million)
  • Table 86 South Africa Postmenopausal Osteoporosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Postmenopausal Osteoporosis Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Postmenopausal Osteoporosis Treatment Market, by Type, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia Postmenopausal Osteoporosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 90 UAE Postmenopausal Osteoporosis Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 91 UAE Postmenopausal Osteoporosis Treatment Market, by Type, 2018 - 2030 (USD Million)
  • Table 92 UAE Postmenopausal Osteoporosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Postmenopausal Osteoporosis Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Postmenopausal Osteoporosis Treatment Market, by Type, 2018 - 2030 (USD Million)
  • Table 95 Kuwait Postmenopausal Osteoporosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Postmenopausal Osteoporosis Treatment Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation Drug Class
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Drug Class, Type and Distribution Channel outlook (USD Million)
  • Fig. 10 Competitive landscape
  • Fig. 11 Postmenopausal Osteoporosis Treatment Market dynamics
  • Fig. 12 Postmenopausal Osteoporosis Treatment Market: Porter's five forces analysis
  • Fig. 13 Postmenopausal Osteoporosis Treatment Market: PESTLE analysis
  • Fig. 14 Postmenopausal Osteoporosis Treatment Market: Drug Class segment dashboard
  • Fig. 15 Postmenopausal Osteoporosis Treatment Market: Drug Class market share analysis, 2024 & 2030
  • Fig. 16 Branded market, 2018 - 2030 (USD Million)
  • Fig. 17 Generics market, 2018 - 2030 (USD Million)
  • Fig. 18 Postmenopausal Osteoporosis Treatment Market: Type segment dashboard
  • Fig. 19 Postmenopausal Osteoporosis Treatment Market: Type market share analysis, 2024 & 2030
  • Fig. 20 Bisphosphonates market, 2018 - 2030 (USD Million)
  • Fig. 21 Parathyroid Hormone Therapy market, 2018 - 2030 (USD Million)
  • Fig. 22 Calcitonin market, 2018 - 2030 (USD Million)
  • Fig. 23 Selective Estrogen Inhibitors Modulator (SERM) market, 2018 - 2030 (USD Million)
  • Fig. 24 Rank Ligand Inhibitors market, 2018 - 2030 (USD Million)
  • Fig. 25 Other Products market, 2018 - 2030 (USD Million)
  • Fig. 26 Postmenopausal Osteoporosis Treatment Market: Distribution Channel segment dashboard
  • Fig. 27 Postmenopausal Osteoporosis Treatment Market: Distribution Channel market share analysis, 2024 & 2030
  • Fig. 28 Hospital Pharmacies market, 2018 - 2030 (USD Million)
  • Fig. 29 Retail Pharmacies market, 2018 - 2030 (USD Million)
  • Fig. 30 Online Pharmacies market, 2018 - 2030 (USD Million)
  • Fig. 31 Postmenopausal Osteoporosis Treatment Market revenue, by region
  • Fig. 32 Regional marketplace: Key takeaways
  • Fig. 33 Regional marketplace: Key takeaways
  • Fig. 34 North America Postmenopausal Osteoporosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 35 U.S. country dynamics
  • Fig. 36 U.S. Postmenopausal Osteoporosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 37 Canada country dynamics
  • Fig. 38 Canada Postmenopausal Osteoporosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 39 Mexico country dynamics
  • Fig. 40 Mexico Postmenopausal Osteoporosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 41 Europe Postmenopausal Osteoporosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 42 UK country dynamics
  • Fig. 43 UK Postmenopausal Osteoporosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 44 Germany country dynamics
  • Fig. 45 Germany Postmenopausal Osteoporosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 46 France country dynamics
  • Fig. 47 France Postmenopausal Osteoporosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 48 Italy country dynamics
  • Fig. 49 Italy Postmenopausal Osteoporosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 50 Spain country dynamics
  • Fig. 51 Spain Postmenopausal Osteoporosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 52 Norway country dynamics
  • Fig. 53 Norway Postmenopausal Osteoporosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 54 Sweden country dynamics
  • Fig. 55 Sweden Postmenopausal Osteoporosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 56 Denmark country dynamics
  • Fig. 57 Denmark Postmenopausal Osteoporosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 58 Asia Pacific Postmenopausal Osteoporosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 59 Japan country dynamics
  • Fig. 60 Japan Postmenopausal Osteoporosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 61 China country dynamics
  • Fig. 62 China Postmenopausal Osteoporosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 63 India country dynamics
  • Fig. 64 India Postmenopausal Osteoporosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 65 Australia country dynamics
  • Fig. 66 Australia Postmenopausal Osteoporosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 67 South Korea country dynamics
  • Fig. 68 South Korea Postmenopausal Osteoporosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 69 Thailand country dynamics
  • Fig. 70 Thailand Postmenopausal Osteoporosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 71 Latin America Postmenopausal Osteoporosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 72 Brazil country dynamics
  • Fig. 73 Brazil Postmenopausal Osteoporosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 74 Argentina country dynamics
  • Fig. 75 Argentina Postmenopausal Osteoporosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 76 MEA Postmenopausal Osteoporosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 77 South Africa country dynamics
  • Fig. 78 South Africa Postmenopausal Osteoporosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 79 Saudi Arabia country dynamics
  • Fig. 80 Saudi Arabia Postmenopausal Osteoporosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 81 UAE country dynamics
  • Fig. 82 UAE Postmenopausal Osteoporosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 83 Kuwait country dynamics
  • Fig. 84 Kuwait Postmenopausal Osteoporosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 85 Company categorization
  • Fig. 86 Company market position analysis
  • Fig. 87 Strategic framework